Quick answer
- No, men cannot have PMOS (PCOS). PMOS (Polyendocrine Metabolic Ovarian Syndrome) is defined by ovarian function, so by definition it is a female condition.
- But there is a recognised "male equivalent." Brothers, sons and fathers of women with PMOS carry the same insulin-resistance and androgen-metabolism genes. Those genes have no ovaries to act on in men, so they show up another way.
- The male phenotype: premature male-pattern baldness (often before age 35), insulin resistance, lower SHBG, and higher rates of metabolic syndrome and type 2 diabetes.
- The evidence is direct. Brothers of women with PMOS have elevated DHEA-S (Legro 2002). Sons show adverse metabolic markers by adolescence (Recabarren 2008). Early baldness is an independent marker of insulin resistance (Matilainen 2000).
- What to do: a man in a PMOS family should get screened for insulin resistance, and the same insulin-friendly way of eating that helps her helps him too.
Feeding a household where someone has PMOS? Build one insulin-friendly plan everyone eats.
If your wife, sister, daughter or mother has PMOS (the new name for PCOS as of 12 May 2026), it is reasonable to ask whether men can have it too, and whether the men in the family share the risk. The short answer: men cannot have PMOS itself, because it is defined by the ovaries. But the genetics are shared, and they produce a recognisable male phenotype. This guide explains what that phenotype looks like, what the research shows, and what a man in a PMOS family should actually do about it.
Can a man have PMOS or PCOS?
No. PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. The diagnosis depends on ovarian features: irregular ovulation, polycystic ovaries on ultrasound, and androgen excess expressed through a female endocrine system. A man does not have ovaries, so he cannot meet the diagnostic criteria. Any source that describes a man as "having PMOS" or "having PCOS" is using the term loosely.
This matters because it sets up the right question. The useful question is not "can he get the same diagnosis" but "does he carry the same risk, and how would it show up." That is where the male equivalent comes in.
What "the male equivalent of PMOS" actually means
PMOS runs in families. It is polygenic, which means many genes contribute, and the genes that contribute most affect two systems: insulin signalling and androgen metabolism. Those genes are inherited by sons as well as daughters.
In a daughter, the genes act on the ovaries and can produce PMOS. In a son, there are no ovaries for the genes to act on, so the same inherited tendency shows up in the tissues men do have: hair follicles, the liver, muscle, and fat. The result is a metabolic and hair-loss pattern that researchers call the male equivalent or the male phenotype of PCOS. It is a pattern of inherited risk, not a formal diagnosis.
The shared genetics: one genotype, two phenotypes
The simplest way to picture it is one genotype producing two phenotypes. The shared genotype is the inherited tendency toward insulin resistance and altered androgen handling. The phenotype it produces depends on the body it lands in.
- In women: ovaries are present, so the genes can drive the full PMOS picture, irregular cycles, high androgens, polycystic ovaries, insulin resistance.
- In men: no ovaries, so the genes show up as early male-pattern baldness, insulin resistance, lower SHBG, and a higher chance of metabolic syndrome and type 2 diabetes.
This is why a brother can look metabolically "fine" on the surface while carrying real inherited risk, and why early hair loss can be the first visible clue.
The male phenotype: what it looks like
The male equivalent is not one symptom. It is a cluster, and not every man shows every feature.
- Premature male-pattern baldness. Androgenetic alopecia that starts early, often before age 35, is the most visible marker.
- Insulin resistance. Cells respond less well to insulin, so the pancreas compensates with higher insulin output. Fasting insulin is often the first abnormal lab.
- Lower SHBG. Sex-hormone-binding globulin falls when insulin is chronically high, the same mechanism seen in women with PMOS.
- Central weight gain. Fat tends to accumulate around the abdomen, the most metabolically active and highest-risk pattern.
- Higher metabolic-syndrome and type 2 diabetes risk. The clustering of raised blood pressure, raised triglycerides, low HDL, and high fasting glucose.
Because most of these are silent for years, men in PMOS families often do not know they carry the risk until a routine blood test or, sometimes, until the hair loss prompts a question.
Evidence: brothers of women with PMOS
One of the cleanest lines of evidence comes from studying brothers. Legro and colleagues reported in the Journal of Clinical Endocrinology and Metabolism (2002) that brothers of women with PCOS had significantly elevated DHEA-S, an adrenal androgen, compared with controls. That is a direct hormonal fingerprint of the shared inheritance, measurable in men who do not and cannot have PMOS themselves.
Later family studies extended the picture to insulin handling, showing that male first-degree relatives tend toward the same insulin-resistance profile seen in their sisters. The androgen and metabolic traits travel together through the family.
Evidence: sons of women with PMOS
The risk appears early. Recabarren and colleagues (Journal of Clinical Endocrinology and Metabolism, 2008) studied sons of women with PCOS and found higher fasting insulin and adverse metabolic markers compared with sons of unaffected women, in some cases detectable by adolescence. This does not mean every son will develop diabetes. It means the inherited metabolic tendency is present early enough that early action, diet, activity, and routine screening, has the most leverage.
For a fuller treatment of this, see the dedicated spoke on sons of mothers with PMOS and inherited metabolic risk.
Early male-pattern baldness as a warning sign
Hair loss is the most visible expression of the male phenotype, and it carries real information. Matilainen and colleagues reported in The Lancet (2000) that early-onset male-pattern baldness is an independent marker of insulin resistance. Sanke and colleagues (JAMA Dermatology, 2016) compared men with early androgenetic alopecia to women with PCOS and found the men shared a parallel hormonal and metabolic profile, in effect a phenotypic equivalent.
The practical takeaway: a man who started balding young, especially with a family history of PMOS, has a reasonable case to ask his doctor about insulin resistance. The hair loss itself may not be reversible, but the underlying metabolic risk is very much modifiable. The spoke on early male-pattern baldness and insulin resistance covers the mechanism and the screening in detail.
What men in a PMOS family should do
The genetics are fixed. The expression is not. Here is the practical order of operations.
- Get screened. Ask a doctor for fasting glucose and fasting insulin (or HOMA-IR), HbA1c, a fasting lipid panel, blood pressure, and waist circumference. These detect insulin resistance and metabolic syndrome before they become type 2 diabetes.
- Eat the insulin-friendly pattern. Moderate carbohydrate, higher protein, higher fibre, a Mediterranean fat profile, and protein-first meals. This is the same upstream lever that helps PMOS, because the upstream driver, insulin resistance, is the same.
- Build muscle. Muscle is the largest insulin-sensitive tissue. Two to three strength sessions a week measurably improves insulin sensitivity over weeks.
- Protect sleep and manage stress. Both move insulin sensitivity directly.
- Re-test. Track fasting insulin and HbA1c over time to see the trend, not just a single snapshot.
The full diet specifics for men sit in the spoke on the insulin-resistance diet for men.
If your partner has PMOS: where you fit
Many men reading this are here because of a partner, not themselves. That is its own role, and it matters. Partner support is one of the strongest predictors of whether a PMOS plan actually sticks. We cover the specifics, what to say, what to avoid, how to be useful through cycles, diagnosis and daily symptom load, in the dedicated guide: PMOS for partners and family.
There is a neat overlap worth naming. If you carry the male phenotype yourself and your partner has PMOS, the same way of eating serves you both. Cooking from one insulin-friendly plan is not a compromise where one person eats "diet food." It is the same food working on the same biology in two people.
How the PCOS Meal Planner helps the whole household
This is where a system beats a stack of separate plans. The PCOS Meal Planner builds insulin-friendly meals designed around the upstream insulin pattern. That pattern is shared by PMOS and by the male equivalent, so one plan covers a wife with PMOS and a husband or son carrying the metabolic risk. You are not running two kitchens. You are running one, and it works on everyone at the table. Build a household plan now.
Frequently asked questions
Can men get PMOS or PCOS?
No. PMOS (the new name for PCOS as of 12 May 2026) is defined by ovarian function, so only people with ovaries can be diagnosed. Men cannot have PMOS itself, but male relatives carry the same insulin-resistance and androgen genes and show a male equivalent phenotype.
What is the male equivalent of PMOS?
A metabolic and hormonal phenotype in brothers, sons and fathers of women with PMOS: premature male-pattern baldness, insulin resistance, lower SHBG, and higher metabolic-syndrome and type 2 diabetes risk. It is a pattern of inherited risk, not a formal diagnosis.
Is male-pattern baldness linked to PMOS?
Indirectly, yes. Both are driven by androgen sensitivity at the hair follicle. Matilainen (The Lancet, 2000) found early-onset male-pattern baldness is an independent marker of insulin resistance. Sanke (JAMA Dermatology, 2016) found men with early baldness had a profile mirroring PCOS in women.
Are sons of women with PCOS at higher risk?
For metabolic risk, research suggests yes. Recabarren (JCEM, 2008) found sons of women with PCOS had higher fasting insulin and adverse metabolic markers, in some cases by adolescence. Worth flagging to a doctor and acting on early with diet, activity and screening.
What should a man in a PMOS family get screened for?
Fasting glucose and fasting insulin (or HOMA-IR), HbA1c, a fasting lipid panel, blood pressure, and waist circumference. These screen for insulin resistance and metabolic syndrome, the core of the male phenotype. Early baldness before 35 is worth mentioning as a possible marker.
Does the same diet that helps PMOS help the men in the family?
Yes. The male phenotype and PMOS share the same upstream driver, insulin resistance, so the same insulin-friendly pattern helps both: moderate carbohydrate, higher protein, higher fibre, Mediterranean fats, protein-first meals. One household plan covers everyone.
Sources and further reading
The male equivalent and family inheritance
- Legro RS et al. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002
- Recabarren SE et al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008
- Cannarella R et al. Does a male polycystic ovarian syndrome equivalent exist? J Endocrinol Invest. 2018
- Sam S et al. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008
Early male-pattern baldness, insulin resistance and androgens
- Matilainen V et al. Early androgenetic alopecia as a marker of insulin resistance. The Lancet. 2000
- Sanke S et al. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016
PCOS / PMOS pathophysiology and inheritance
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited. Endocr Rev. 2012
- Azziz R et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016
Clinical guidelines and patient-facing summaries
- International Evidence-Based Guideline for PCOS (Monash, 2023)
- NHS: Causes of PCOS
- Mayo Clinic: PCOS
How this article was made
The male-equivalent framing draws on the Cannarella et al. 2018 review in the Journal of Endocrinological Investigation on whether a male PCOS equivalent exists. Brother evidence is from Legro et al. 2002 (elevated DHEA-S) in JCEM and the related brother metabolic-phenotype work. Son evidence is from Recabarren et al. 2008 in JCEM. The early-baldness link to insulin resistance is from Matilainen et al. 2000 in The Lancet, and the phenotypic-equivalent comparison from Sanke et al. 2016 in JAMA Dermatology. Shared pathophysiology draws on Diamanti-Kandarakis and Dunaif 2012 and Azziz et al. 2016. Aligned with the 2023 International Evidence-Based Guideline for PCOS. PMOS is the new name for PCOS as of 12 May 2026; the underlying biology is unchanged. This article is informational and not medical advice.
Related reading
- PCOS is now PMOS: the full renaming explainer
- Can men get PMOS (PCOS)? The honest answer
- Early male-pattern baldness and insulin resistance
- Sons of mothers with PMOS: the inherited metabolic risk
- The insulin-resistance diet for men
- PMOS for partners and family: a practical support guide
- The PMOS hormone cascade in one diagram
Community Comments
Add a comment